Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder
- PMID: 22015805
- PMCID: PMC3381430
- DOI: 10.1097/FBP.0b013e32834d623e
Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder
Abstract
Despite its abuse potential, methylphenidate (MPH) is widely prescribed for treatment of attention-deficit hyperactivity disorder (ADHD). The purpose of the present study was to examine MPH self-administration in a rat model of ADHD. Experiment 1 examined the acquisition of MPH self-administration and assessed the MPH dose-effect curve in spontaneously hypertensive rats (SHR), an inbred rat model of ADHD, Wistar Kyotos (WKY), the progenitor strain for SHR, and Sprague-Dawley (SD), an outbred control strain. Experiment 2 replicated Experiment 1, but replaced MPH infusions with sucrose pellets. Initial acquisition of MPH self-administration was greater in SHR and SD than WKY. However, with extended training using an incrementing fixed ratio schedule SHR and WKY did not differ in responding for MPH using the training dose (0.3 mg/kg/infusion) or other unit doses, except that SHR showed greater responding than WKY at 0.1 mg/kg/infusion. SHR also showed greater acquisition and maintenance of sucrose-reinforced responding compared with both WKY and SD. Greater initial acquisition of MPH self-administration in SHR than WKY may not be due to a strain-specific difference in sensitivity to the reinforcing effect of MPH.
Conflict of interest statement
The authors have no conflicts of interest.
Figures








Similar articles
-
Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder.Behav Brain Funct. 2012 Feb 28;8(1):10. doi: 10.1186/1744-9081-8-10. Behav Brain Funct. 2012. PMID: 22369105 Free PMC article.
-
Chronic Methylphenidate Alters Tonic and Phasic Glutamate Signaling in the Frontal Cortex of a Freely-Moving Rat Model of ADHD.Neurochem Res. 2019 Jan;44(1):89-101. doi: 10.1007/s11064-018-2483-1. Epub 2018 Feb 3. Neurochem Res. 2019. PMID: 29397534
-
Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.J Neurosci Methods. 2015 Aug 30;252:55-63. doi: 10.1016/j.jneumeth.2015.02.002. Epub 2015 Feb 11. J Neurosci Methods. 2015. PMID: 25680322 Free PMC article.
-
Systematic review and meta-analysis of the behavioral effects of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.Neurosci Biobehav Rev. 2019 May;100:166-179. doi: 10.1016/j.neubiorev.2019.02.019. Epub 2019 Feb 28. Neurosci Biobehav Rev. 2019. PMID: 30826386
-
Drug reinforcement in a rat model of attention deficit/hyperactivity disorder--the Spontaneously Hypertensive Rat (SHR).Curr Drug Abuse Rev. 2009 May;2(2):177-83. doi: 10.2174/1874473710902020177. Curr Drug Abuse Rev. 2009. PMID: 19630747 Review.
Cited by
-
Spontaneously Hypertensive Rat substrains show differences in model traits for addiction risk and cocaine self-administration: Implications for a novel rat reduced complexity cross.Behav Brain Res. 2021 Aug 6;411:113406. doi: 10.1016/j.bbr.2021.113406. Epub 2021 Jun 5. Behav Brain Res. 2021. PMID: 34097899 Free PMC article.
-
Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD.Pharmacol Biochem Behav. 2016 Jun;145:24-6. doi: 10.1016/j.pbb.2016.03.009. Epub 2016 Mar 22. Pharmacol Biochem Behav. 2016. PMID: 27012495 Free PMC article. No abstract available.
-
The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.CNS Drugs. 2012 Aug 1;26(8):663-90. doi: 10.2165/11634390-000000000-00000. CNS Drugs. 2012. PMID: 22784018 Review.
-
Distinct relationships between risky decision making and cocaine self-administration under short- and long-access conditions.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 2;98:109791. doi: 10.1016/j.pnpbp.2019.109791. Epub 2019 Oct 30. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 31676462 Free PMC article.
-
Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.Pharmacol Biochem Behav. 2015 Apr;131:51-6. doi: 10.1016/j.pbb.2015.01.019. Epub 2015 Jan 31. Pharmacol Biochem Behav. 2015. PMID: 25643872 Free PMC article.
References
-
- Adriani W, Caprioli A, Granstrem O, Carli M, Laviola G. The spontaneously hypertensive-rat as an animal model of ADHD: evidence for impulsive and non-impulsive subpopulations. Neurosci Biobehav Rev. 2003;27:639–651. - PubMed
-
- Alsop B. Problems with spontaneously hypertensive rats (SHR) as a model of attention-deficit/hyperactivity disorder (AD/HD) J Neurosci Methods. 2007;162:42–8. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Association; 2000.
-
- Amini B, Yang PB, Swann AC, Dafny N. Differential locomotor responses in male rats from three strains to acute methylphenidate. Int J Neurosci. 2004;114:1063–84. - PubMed
-
- Barbaresi WJ, Katusic SK, Colligan RC, Oankratz VZ, Weber AL, Mrazek KJ, Jacobsen SJ. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med. 2002;156:217–24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical